Abstract 2082: NMS-E668, a potent and selective RET kinase inhibitor characterized by specificity towards VEGFR2 and high antitumor efficacy against RET-driven models

Elena Ardini, Maria Menichincheri, Nilla Avanzi et al.|Cancer Research|2017

Cited by 1